Nasal Cannula Global Market Report 2025

A nasal cannula is a medical device designed to provide supplemental oxygen to patients in need of respiratory assistance. It features two small prongs that fit into the nostrils, connected by a thin tube to an oxygen source. This device delivers a continuous flow of oxygen, allowing the patient to breathe comfortably while still being able to speak and eat.

Nasal cannulas are primarily available in two types, low-flow and high-flow. A low-flow nasal cannula is a device that delivers a modest amount of oxygen through prongs placed in the nostrils to assist patients with breathing difficulties. Constructed from materials such as plastic and silicone, it comes in various sizes, such as neonate, infant, child, and adult, and is available in multiple prong designs, including straight, curved, flared, and others. It is used in diverse healthcare settings, including hospitals, ambulatory healthcare services, long-term care centers, and other medical environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The nasal cannula market research report is one of a series of new reports from The Business Research Company that provides nasal cannula market statistics, including the nasal cannula industry global market size, regional shares, competitors with the nasal cannula market share, detailed nasal cannula market segments, market trends, and opportunities, and any further data you may need to thrive in the nasal cannula industry. This nasal cannula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nasal cannula market size has grown strongly in recent years. It will grow from $8.93 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing personalized patient care, increasing prevalence of obstructive sleep apnea, increasing awareness of respiratory diseases, rising changes in lifestyle, and rising population.

The nasal cannula market size is expected to see strong growth in the next few years. It will grow to $14.05 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to the increasing prevalence of respiratory diseases, increasing healthcare expenditure, increasing geriatric population, increasing government initiatives, and increasing number of surgeries. Major trends in the forecast period include technological advancement, strategic collaboration, facility expansion, investment in research and development, and focus on product launch.

The forecast of 9.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to increase U.S. healthcare costs by raising prices of high-flow oxygen delivery systems and silicone nasal interfaces imported from China and Mexico, potentially compromising respiratory therapy access and elevating pulmonary department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of respiratory diseases is a key factor driving the expansion of the nasal cannula market. These diseases, which affect the lungs and airways, hinder proper breathing and oxygen exchange. The rise in respiratory conditions is primarily due to factors such as air pollution, smoking, viral infections, and heightened exposure to allergens. Nasal cannulas are commonly used to provide supplemental oxygen directly into the nostrils, helping to improve oxygen levels for patients with breathing difficulties. For example, in June 2024, the American Lung Association, a US-based non-profit organization, reported that in 2022, approximately 44.2 million Americans, or 13.5% of the population, had been diagnosed with asthma by a healthcare professional. As a result, the increasing number of respiratory diseases contributes to the growth of the nasal cannula market.

Leading companies in the nasal cannula market are concentrating on technological advancements, such as low-flow nasal cannulas, to improve patient comfort, enhance oxygen delivery efficiency, and fulfill specific clinical needs. A low-flow nasal cannula is a device that administers supplemental oxygen at lower flow rates, typically between 1 and 6 liters per minute, through two prongs placed in the nostrils. For example, in May 2024, CNSAC MedShop, a diagnostics and consumables company based in Germany, launched NasalOxy, an innovative, patented low-flow nasal cannula aimed at overcoming the limitations of conventional oxygen delivery methods. This cutting-edge device ensures exceptional comfort and effectiveness for patients requiring long-term oxygen therapy while providing flexibility for supporting both nasal and oral breathing. The design of NasalOxy minimizes contact with the mucous membranes, reducing irritation and discomfort, and eliminates common side effects typically associated with traditional nasal cannulas.

In January 2022, ICU Medical Inc., a US-based manufacturer of medical devices and systems, purchased Smiths Medical from Smiths Group plc for $2.5 billion. This acquisition is anticipated to boost ICU Medical's market position, expand its product portfolio, and improve operational efficiencies, paving the way for sustained growth and innovation in the healthcare industry. Smiths Medical Inc., a US-based company, specializes in the provision of nasal cannulas.

Major players in the nasal cannula market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company, ResMed Inc., Teleflex Incorporated, Angiplast Pvt. Ltd., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Well Lead Medical Co. Ltd., GaleMed Corp., Vapotherm Inc., Salter Labs Inc., Dynarex Corporation, Mais India Medical Devices Pvt. Ltd., Allied Medical LLC, Besmed Health Business Corp., Flexicare Medical Ltd., Medin Medical Innovations AB, Airways Surgical Pvt. Ltd., Great Group Medical Co. Ltd., and HUM GmbH.

North America was the largest region in the nasal cannula market in 2024. The regions covered in nasal cannula report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nasal cannula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nasal cannula market consists of sales of standard nasal cannulas, pediatric nasal cannulas, disposable nasal cannulas, and reusable nasal cannulas. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nasal Cannula Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nasal cannula market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nasal cannula ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nasal cannula market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Low Flow Nasal Cannula; High Flow Nasal Cannula
• 2) By Material: Plastic; Silicone
• 3) By Size: Neonate; Infant; Child; Adult
• 4) By Prongs: Straight; Curved; Flared; Other Prongs
• 5) By End User: Hospitals; Ambulatory Healthcare Services; Long Term Care Centers; Others End Users
• Subsegments:
• 1) By Low Flow Nasal Cannula: Adult Low Flow Nasal Cannula; Pediatric Low Flow Nasal Cannula; Disposable Low Flow Nasal Cannula; Reusable Low Flow Nasal Cannula
• 2) By High Flow Nasal Cannula: Adult High Flow Nasal Cannula; Pediatric High Flow Nasal Cannula; Disposable High Flow Nasal Cannula; Reusable High Flow Nasal Cannula
• Companies Mentioned: Cardinal Health Inc.; Medline Industries Inc.; Becton Dickinson and Company; ResMed Inc.; Teleflex Incorporated; Angiplast Pvt. Ltd.; Fisher & Paykel Healthcare Limited; Drive DeVilbiss Healthcare LLC; Well Lead Medical Co. Ltd.; GaleMed Corp.; Vapotherm Inc.; Salter Labs Inc.; Dynarex Corporation; Mais India Medical Devices Pvt. Ltd.; Allied Medical LLC; Besmed Health Business Corp.; Flexicare Medical Ltd.; Medin Medical Innovations AB; Airways Surgical Pvt. Ltd.; Great Group Medical Co. Ltd.; HUM GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.